277 related articles for article (PubMed ID: 14693325)
1. Hypercoagulability in sickle cell disease: a curious paradox.
Ataga KI; Orringer EP
Am J Med; 2003 Dec; 115(9):721-8. PubMed ID: 14693325
[TBL] [Abstract][Full Text] [Related]
2. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
Ataga KI; Cappellini MD; Rachmilewitz EA
Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
[TBL] [Abstract][Full Text] [Related]
3. Thrombosis and sickle cell disease.
De Franceschi L; Cappellini MD; Olivieri O
Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulability in sickle cell disease: new approaches to an old problem.
Ataga KI; Key NS
Hematology Am Soc Hematol Educ Program; 2007; ():91-6. PubMed ID: 18024615
[TBL] [Abstract][Full Text] [Related]
6. Association of coagulation activation with clinical complications in sickle cell disease.
Ataga KI; Brittain JE; Desai P; May R; Jones S; Delaney J; Strayhorn D; Hinderliter A; Key NS
PLoS One; 2012; 7(1):e29786. PubMed ID: 22253781
[TBL] [Abstract][Full Text] [Related]
7. Recent Insights Into the Regulation of Coagulation and Thrombosis.
Li X; Sim MMS; Wood JP
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):e119-e125. PubMed ID: 32320291
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
Stuart MJ; Setty BN
Pediatr Pathol Mol Med; 2001; 20(1):27-46. PubMed ID: 12673843
[TBL] [Abstract][Full Text] [Related]
9. Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.
Noubouossie D; Key NS; Ataga KI
Blood Rev; 2016 Jul; 30(4):245-56. PubMed ID: 26776344
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiplatelet and anticoagulant medications on the vasoocclusive and thrombotic complications of sickle cell disease: A review of the literature.
Charneski L; Congdon HB
Am J Health Syst Pharm; 2010 Jun; 67(11):895-900. PubMed ID: 20484211
[TBL] [Abstract][Full Text] [Related]
11. Elevated hypercoagulability markers in hemoglobin SC disease.
Colella MP; de Paula EV; Machado-Neto JA; Conran N; Annichino-Bizzacchi JM; Costa FF; Olalla Saad ST; Traina F
Haematologica; 2015 Apr; 100(4):466-71. PubMed ID: 25596272
[TBL] [Abstract][Full Text] [Related]
12. Hypercoagulability in sickle cell disease and beta-thalassemia.
Singer ST; Ataga KI
Curr Mol Med; 2008 Nov; 8(7):639-45. PubMed ID: 18991650
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease.
Garrido VT; Proença-Ferreira R; Dominical VM; Traina F; Bezerra MA; de Mello MR; Colella MP; Araújo AS; Saad ST; Costa FF; Conran N
Br J Haematol; 2012 Sep; 158(6):788-97. PubMed ID: 22775554
[TBL] [Abstract][Full Text] [Related]
14. Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.
Browne PV; Mosher DF; Steinberg MH; Hebbel RP
Am J Hematol; 1996 Apr; 51(4):296-301. PubMed ID: 8602630
[TBL] [Abstract][Full Text] [Related]
15. [Hemostasis alterations in sickle cell syndrome].
Higuera D; Bravo M; Guerrero B
Invest Clin; 2014 Jun; 55(2):173-84. PubMed ID: 24974633
[TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease: an inherited thrombophilia.
Wun T; Brunson A
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):640-647. PubMed ID: 27913540
[TBL] [Abstract][Full Text] [Related]
17. Calpain-1 regulates platelet function in a humanized mouse model of sickle cell disease.
Nwankwo JO; Gremmel T; Gerrits AJ; Mithila FJ; Warburton RR; Hill NS; Lu Y; Richey LJ; Jakubowski JA; Frelinger AL; Chishti AH
Thromb Res; 2017 Dec; 160():58-65. PubMed ID: 29101791
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of inflammation, growth factor, and coagulation activation in patients with sickle cell disease.
Qari MH; Dier U; Mousa SA
Clin Appl Thromb Hemost; 2012; 18(2):195-200. PubMed ID: 21949038
[TBL] [Abstract][Full Text] [Related]
19. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion.
Francis RB
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):341-53. PubMed ID: 1893065
[TBL] [Abstract][Full Text] [Related]
20. Prothrombotic aspects of sickle cell disease.
Sparkenbaugh E; Pawlinski R
J Thromb Haemost; 2017 Jul; 15(7):1307-1316. PubMed ID: 28671346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
